Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023

BUY
$238.39 - $265.32 $20,024 - $22,286
84 Added 4.81%
1,831 $483,000
Q1 2023

May 04, 2023

SELL
$229.71 - $259.35 $133,002 - $150,163
-579 Reduced 24.89%
1,747 $432,000
Q4 2022

Feb 13, 2023

SELL
$218.29 - $256.91 $106,962 - $125,885
-490 Reduced 17.4%
2,326 $591,000
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $12,400 - $64,207
243 Added 9.44%
2,816 $628,000
Q2 2022

Aug 12, 2022

BUY
$234.74 - $275.42 $107,041 - $125,591
456 Added 21.54%
2,573 $634,000
Q1 2022

May 16, 2022

BUY
$243.64 - $270.48 $143,503 - $159,312
589 Added 38.55%
2,117 $563,000
Q4 2021

Feb 15, 2022

BUY
$230.08 - $250.94 $2,530 - $2,760
11 Added 0.73%
1,528 $384,000
Q3 2021

Nov 15, 2021

BUY
$232.72 - $256.47 $353,036 - $389,064
1,517 New
1,517 $373,000
Q2 2021

Aug 16, 2021

SELL
$232.65 - $254.58 $1.2 Million - $1.32 Million
-5,169 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$232.09 - $256.88 $600,416 - $664,548
2,587 Added 100.19%
5,169 $1.23 Million
Q2 2020

Aug 14, 2020

BUY
$219.9 - $263.41 $354,258 - $424,353
1,611 Added 165.91%
2,582 $618,000
Q1 2020

May 15, 2020

SELL
$195.69 - $279.01 $182,774 - $260,595
-934 Reduced 49.03%
971 $223,000
Q4 2019

Feb 12, 2020

SELL
$236.45 - $266.82 $772,482 - $871,700
-3,267 Reduced 63.17%
1,905 $518,000
Q2 2019

Aug 15, 2019

BUY
$217.4 - $246.08 $1.12 Million - $1.27 Million
5,172 New
5,172 $1.28 Million
Q2 2019

Aug 14, 2019

SELL
$217.4 - $246.08 $1.07 Million - $1.22 Million
-4,941 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$204.73 - $257.93 $1.01 Million - $1.27 Million
4,941 New
4,941 $1.11 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $68.6B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Little House Capital LLC Portfolio

Follow Little House Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Little House Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Little House Capital LLC with notifications on news.